Profile: Tianyin Pharmaceutical Co Inc (TPI)

TPI on American Stock Exchange

24 Oct 2014
Price Change (% chg)

$0.02 (+3.85%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Tianyin Pharmaceutical Co., Inc. is a pharmaceutical company. Through the Company’s indirect wholly owned subsidiary Chengdu Tianyin Pharmaceutical Co., Ltd. (Chengdu Tianyin), it is engaged in the development, manufacturing, marketing and sales of patented biopharmaceutical medicines, branded generics, modernized traditional Chinese medicines and other pharmaceuticals in the People’s Republic of China. It is manufacturing a range of 56 products, 23 of which are listed in the highly selective National Medical Reimbursement List (NMRL) and seven are listed in the Essential Drug List (EDL) of the People’s Republic of China.

As of June 30, 2010, the Company had 56 products approved by the State Food and Drug Administration (SFDA) in the People’s Republic of China. As of June 30, 2010, it had 10 drug candidates pending the SFDA’s approval. The Company’s products include Ginkgo Mihuan Oral Liquid, Benorylate Granules, Xuelian Chongcao Oral Solution, Fukangbao Oral Liquid, Xiaoyanlidan Tablets, Qijudihuang Mixture, Yupingfeng Oral Liquid, Sanqi Tablets, Qianggan Syrup and Kangjunxiaoyan capsule.

Company Address

Tianyin Pharmaceutical Co Inc

23rd Floor, Unionsun Yangkuo Pla
No. 2, 3rd block, South Renmin R
CHENGDU   SIC   610041
P: +8628.82002232
F: +8628.85516676

Search Stocks